Key result
Tachykinins exerted gut contractile effects similar to acetylcholine, but responses were reduced to 0%-42% in inflamed ileum (P<0.05) and 0%-17% in inflamed colon (P<0.01) compared to controls.
p-value: p=<0.05
Tachykinins exert gut contractile effects predominantly through neurokinin 2 receptors, but these responses are greatly reduced in inflamed tissues of inflammatory bowel disease.
Impaired tachykinin contractility in inflamed animal gut suggests caution for IBD therapies; leaves open receptor mechanisms in human disease.
BACKGROUND: Tachykinins and acetylcholine are main physiological motility stimulators in the gut by their effects exerted through neurokinin and muscarinic receptors. METHODS: Longitudinal and circular muscle strips from normal ileum and colon or corresponding tissues from patients with inflammatory bowel disease were studied in organ baths. Contractile responses to the tachykinins substance P, neurokinin A, neurokinin B and neuropeptide gamma and specific analogs for their respective receptors were compared to acetylcholine. RESULTS: Acetylcholine caused concentration-dependent phasic contractions in longitudinal and circular muscle of normal ileum and colon (both P < 0.01). In inflamed tissues, contractile responses were reduced to 17%-33% in ileum (P < 0.05) and 3%-26% in colon (P < 0.01). Both natural tachykinins and their specific analogs caused concentration-dependent phasic, tonic and rhythmic contractions (each P < 0.01). Neuropeptide gamma was most potent in contracting the ileum and colon, followed by neurokinin A, substance P and neurokinin B, let alone longitudinal muscle of the ileum where neuropeptide gamma and neurokinin A were equipotent. Of the tachykinin analogs, Nle10-NKA(4-10) was more potent than substance P methyl ester and senktide, indicating neurokinin 2 receptors are predominant for contractile effects of tachykinins. In inflamed tissues, contractile responses to tachykinins were reduced to 0%-42% in ileum (P < 0.05) and 0%-17% in colon (P < 0.01) compared to controls. CONCLUSION: In humans, tachykinins exert gut contractile effects, of similar strength as acetylcholine, predominantly through activation of neurokinin 2 receptors. These responses are greatly reduced in inflamed tissues of ulcerative colitis and Crohn disease.
No takes yet. Share an insight, caveat, or question.
A 2001 study studied Inflammatory bowel disease. Tachykinins and specific analogs vs. Acetylcholine and normal tissues was evaluated on Contractile responses in inflamed tissues compared to controls (p=<0.05). Tachykinins exerted gut contractile effects similar to acetylcholine, but responses were reduced to 0%-42% in inflamed ileum (P<0.05) and 0%-17% in inflamed colon (P<0.01) compared to controls.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: